![Francesco Maria Lavino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco Maria Lavino
Algemeen Directeur bij F2G Ltd.
Profiel
Francesco Maria Lavino is currently the Chief Executive Officer & Director at F2G Ltd.
and the President & Director at F2g Inc. He previously worked as the Executive Director at Merck & Co., Inc. from 2011 to 2013, the Vice President-International Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015, and the Associate Vice President at Merck & Co., Inc. from 2015 to 2017.
He also served as the Chief Commercial Officer at Nabriva Therapeutics Plc.
Lavino received his undergraduate degree from Università degli Studi di Napoli Federico II and his MBA from SDA Bocconi School of Management.
Actieve functies van Francesco Maria Lavino
Bedrijven | Functie | Begin |
---|---|---|
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Algemeen Directeur | 12-04-2021 |
F2g Inc. | President | - |
Eerdere bekende functies van Francesco Maria Lavino
Bedrijven | Functie | Einde |
---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | 01-07-2017 |
CUBIST PHARMACEUTICALS INC | Verkoop & Marketing | 01-09-2015 |
MERCK & CO., INC. | Directeur/Bestuurslid | 01-11-2013 |
NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | - |
Opleiding van Francesco Maria Lavino
Università degli Studi di Napoli Federico II | Undergraduate Degree |
SDA Bocconi School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NABRIVA THERAPEUTICS PLC | Health Technology |
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
F2g Inc. |